# A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

> **NCT01606176** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 70 (actual)

## Conditions studied

- Pain
- Multiple Sclerosis

## Interventions

- **DRUG:** GW-1000-02
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01606176
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01606176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01606176, "A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01606176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*